30 April 2025 in Journal of Clinical Practice
МКМамашаев Нурмухамед Каримович
Мамашаев Нурмухамед Каримович
+3
Selective dorsal rhizotomy is one of the methods used for surgical correction of spasticity in the muscles of the lower limbs with high level of evidence among the patients with cerebral palsy. At the same time, the long-term positive results after surgery can be achieved only when combining surgical treatment with rehabilitation activities. The provided literature review contains a historic reference on the development of the technology along with the current data on the efficiency of surgical intervention with the analyzed research results in terms of the methods and the specific features of rehabilitation among the patients with the diagnosis of cerebral palsy after selective dorsal rhizotomy. Just like other treatment methods, selective dorsal rhizotomy does not exclude the probability of developing complications, but the individual approach during the course of combined, long-term and intensive rehabilitation, as well as following the clinical protocols, can minimize these risks. Stable improvement of motor functions, as well as an increase in the quality of life among patients after selective dorsal rhizotomy and combined rehabilitation courses, confirm the efficiency and the perspectivity of this method.
25 February 2022 in Vestnik
Г.А. Мухамбетова, А.А. Ахметче, Б.К. Демесинова, С.Б. Есентаева, Д.А. Митрохин МЕТОДЫ ФАРМАКОТЕРАПИИ СИНДРОМА СПАСТИЧНОСТИ ПРИ ЦЕРЕБРАЛЬНЫХ ПАРАЛИЧАХ (ОБЗОР ЛИТЕРАТУРЫ)...
15 April 2022 in Journal of Clinical Practice
Background: Idiopathic longitudinally extensive transverse myelitis is defined as a focal spinal cord lesion that involves three or more segments of the spinal cord as shown by neuroimaging, and results in a profound disability. The clinical picture of a patient with idiopathic longitudinally advanced transverse myelitis is often dramatic and may consist of paraparesis or tetraparesis, sensory disturbances, and pelvic dysfunction. Idiopathic longitudinally advanced transverse myelitis is a common manifestation of the neuromyelitis optica spectrum disorders, but can also occur in various other autoimmune and inflammatory diseases of the CNS, such as multiple sclerosis, sarcoidosis, or Sjogrens syndrome, or in infectious diseases involving the CNS. It is less likely to occur in isolation, as the only manifestation of a demyelinating disease of the nervous system of an unknown etiology (idiopathic myelitis). Clinical case description: The clinical observation presented in the article demonstrates the difficulties of establishing a nosological diagnosis in the case of a monophasic course of TM in the absence of other autoimmune and infectious diseases of the central nervous system. The patient with idiopathic longitudinally distributed TM had no visual disturbances and no antibodies to aquaporin 4 and to myelin oligodendrocyte glycoprotein (MOG-IgG) with twice repeated tests. Conclusion: In this regard, it is important to dynamically monitor the clinical manifestations and MRI signs in patients with an isolated lesion of a demyelinating nature in the form of longitudinally extensive transverse myelitis.
23 April 2024 in S.S. Korsakov Journal of Neurology and Psychiatry
Chronic cerebral ischemia (CCI) is one of the most common forms of cerebrovascular disease, which affects a significant number of patients, often leading to disability, cognitive impairment and dementia. The analysis of modern data on the pathogenesis and risk factors for the development of CCI, as well as on the mechanisms of action of Mexidol on various links in the pathogenesis of CCI. A systematic search was conducted in the PubMed, MEDLINE and Google Scholar databases, on Russian and English-language sites with open access publications on the problem of CCI and on the drug Mexidol in the period from 2014 to 2024. The analysis included randomized controlled trials, meta-analyses and original studies, excluded low-confidence studies, retrospective studies, literature reviews, systematic reports and descriptions of clinical cases. It has been established that the use of Mexidol leads to a significant regression of cognitive, emotional, autonomic and motor disorders in CCI. An important indicator of the effectiveness of Mexidol is the high degree of patient adherence to therapy. It is recommended to start treatment with injection of Mexidol, followed by a transition to tablet forms.
25 February 2022 in Vestnik
Б.Р.Нурмухамбетова, А.М. Әлімжан, А.А. Ескалиева, Б.К. Демесинова, А.Ж. Шалбай ДИФФЕРЕНЦИАЛЬНО ДИАГНОСТИЧЕСКИЕ КРИТЕРИИ У БОЛЬНОГО С МОЧЕПОЛОВОЙ ПАТОЛОГИЕЙ ОСЛОЖНЕННОЙ ИНСУЛЬТОМ (клинический...
20 December 2024 in International Professional Journal "Medicine"